Evidence map›Paper›PMID 39869661›Full record

ArticlePloS one2025

Genomic characteristics and molecular epidemiology of MRSA from medical centers in Mexico: Results from the Invifar network.

Gabriela Echaniz-Avilés, Luis Ángel Núñez-García, Eduardo Rodríguez-Noriega, Consuelo Velázquez-Acosta, Luis Esaú López-Jácome, Eduardo López-Gutiérrez, Talia Pérez-Vicelis, Cristina Torres-Báez, Ulises Garza-Ramos, Nadia Rodríguez-Medina and 6 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Whole-genome sequencing ofMicrobiology spectrum · 2026
    Article
  3. Methicillin-ResistantInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Trends, Seasonality, and the Impact of COVID-19 on ClinicalAntibiotics (Basel, Switzerland) · 2026
    Article
  7. Emergence of a methicillin-susceptibleFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gabriela Echaniz-AvilésCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.ORCID 0000-0002-3167-0168
Luis Ángel Núñez-GarcíaDepartamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.ORCID 0009-0001-8058-4100
Eduardo Rodríguez-NoriegaInstituto de Patología Infecciosa y Experimental, Centro Universitario de Ciencias de la Salud Universidad de Guadalajara, Guadalajara, Jalisco, México.
Consuelo Velázquez-AcostaInstituto Nacional de Cancerología, Ciudad de México, México.
Luis Esaú López-JácomeInstituto Nacional de Rehabilitación Luis Guillermo Ibarra, Ciudad de México, México.ORCID 0000-0001-7387-0937
Eduardo López-GutiérrezHospital Regional de Alta Especialidad de Oaxaca, Oaxaca, Oaxaca, México.
Talia Pérez-VicelisHospital Regional de alta especialidad Bicentenario de la independencia, Tultitlán de Mariano Escobedo, Estado de México, México.
Cristina Torres-BáezHospital General Dr. Miguel Silva, Morelia, Michoacán, México.
Ulises Garza-RamosDepartamento de Resistencia Bacteriana, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.ORCID 0000-0002-5013-3050
Nadia Rodríguez-MedinaDepartamento de Resistencia Bacteriana, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Juan Manuel Barajas-MagallónLaboratorio Dipromi, Morelia, Michoacán, México.
Rosario Vázquez-LariosInstituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Aldo Rafael Silva-GamiñoHospital Angeles de Morelia, Morelia, Michoacán, México.
Rafael Franco-CendejasInstituto Nacional de Rehabilitación Luis Guillermo Ibarra, Ciudad de México, México.ORCID 0000-0003-1574-1138
Adolfo Gómez-QuirozLaboratorio de Microbiología, Hospital civil de Guadalajara, Guadalajara, Jalisco, México.
Elvira Garza-GonzálezDepartamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.ORCID 0000-0001-5831-9661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe methicillin-resistant Staphylococcus aureus (MRSA) genome varies by geographical location. This study aims to determine the genomic characteristics of MRSA using whole-genome sequencing (WGS) data from medical centers in Mexico and to explore the associations between antimicrobial resistance genes and virulence factors.

methodsThis study included 27 clinical isolates collected from sterile sites at eight centers in Mexico in 2022 and 2023. Antibiotic susceptibility testing was performed using VITEK 2. In addition, WGS was performed using a NovaSeq platform, and a bioinformatic analysis was conducted using several tools.

resultsIn this study, 21 strains were CC5, five were CC8, and one was CC93. Moreover, six strains were identified as ST5(CC5)-MRSA-IIa- t895, four strains were found to be ST1011(CC5)-MRSA-IIa-t895, five strains were found to be ST1011(CC5)-MRSA-IIa-t9364, one strain was found to be ST1011(CC5)-MRSA-IIa-t8116, another was found to be ST1011(CC5)-MRSA-IIa-t62, three were found to be ST8(CC8)-MRSA-IVa-t8, one strain was ST5(CC5)-MRSA-IVa-t2, one strain was as ST93(CC93)-MRSA-IVa-t3949, two strains were ST9003(CC8)-MRSA-IVa-t18492, and three strains were ST9034(CC5)-MRSA-V-t2. All SCCmec IIa strains showed resistance to levofloxacin and ciprofloxacin, and all but two strains were resistant to clindamycin. Among the strains that harbored the type IIa cassette, most had the aadD, blaZ, and ermA_SDS genes and the erm A gene. Multiple genes for adhesion, enzymes, immune evasion, and secretion system were detected, regardless of SCCmec type. Of the SCCmec IVa strains, most harbored the Panton-Valentine leukocidin encoding genes.

conclusionIn this study, the most frequently detected CC was CC5, followed by CC8, and CC93, and the most frequently detected MRSA ST was ST1011, followed by ST5. Most SCCmec elements were found to be type IIa, followed by type IVa. High MIC values were observed for ciprofloxacin, erythromycin, and clindamycin, particularly within SCCmec IIa. Of the SCCmec IVa strains, most harbored the lukS-PV and lukF-PV genes.

Indexed as

Genome, BacterialMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsGenomicsHumansMexicoMicrobial Sensitivity TestsMolecular EpidemiologyVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsVirulence Factors

Identifiers

PMID39869661
PMCPMC11771916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.